Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Asthma

Standard Treatments and the Single-Inhaler Approach

At a Glance

Nighttime asthma symptoms can mean that asthma control needs review rather than a bedtime-only pill. When prescribed, a MART/SMART inhaler containing an anti-inflammatory steroid and formoterol can provide both maintenance and relief. Inhaler technique, daily use, reflux, and sleep apnea also matter.

When asthma disrupts your sleep, it is a clear message from your body that your current treatment plan warrants clinical review. Modern medical guidelines, such as those from the Global Initiative for Asthma (GINA), no longer view nocturnal asthma as a separate problem to be treated with “nighttime-only” pills. Instead, they emphasize stabilizing your airways 24 hours a day to prevent symptoms from ever starting [1][2].

Important: Inhaler approvals, formulations, and treatment steps vary. Never change your prescribed dosing, substitute inhalers, or combine medications without direct instructions from your prescribing clinician.

The Shift Away from “Relief Only”

For decades, many patients were taught to reach for a SABA (short-acting beta-agonist, such as albuterol) whenever they woke up wheezing. While these “rescue” inhalers quickly relax the muscles around your airways, they do nothing to treat the underlying inflammation that caused the narrowing in the first place [3].

Current guidelines now strongly recommend against using a SABA as your only treatment [4]. Frequent use of a SABA is associated with poorer outcomes and typically indicates that the underlying airway inflammation is undertreated [3][5]. Appropriately prescribed SABA remains a part of some treatment plans when used correctly alongside the recommended daily controller strategy.

The MART/SMART Strategy: A Single-Inhaler Approach

For many adults, a preferred treatment strategy today is known as MART or SMART (Maintenance and Reliever Therapy) [5]. When specifically prescribed by your doctor, you use one single inhaler that contains two medications: an ICS (inhaled corticosteroid) to lower inflammation and formoterol, a fast-acting but long-lasting bronchodilator [6].

How MART works for your 24-hour cycle:

  • Daily Maintenance: For those prescribed MART at higher treatment steps, you take your prescribed puffs every morning and evening to keep your airways stable. (At lower steps, GINA Track 1 uses the inhaler only as-needed.) [6].
  • Nighttime Relief: If you do wake up with symptoms, you use the same inhaler as your reliever. This ensures that every time you treat your symptoms, you are also giving your lungs a tiny “boost” of anti-inflammatory medicine right when they need it most [7][8].

Research has shown that this “Track 1” approach (specifically stepping up to MART) can reduce the risk of severe asthma attacks by 35% to 60% compared to stepping up to or continuing maintenance ICS-LABA plus a standard SABA rescue inhaler [9][2][10].

(Note: Track 2 involves a daily maintenance ICS and a separate SABA rescue inhaler. Not every combination inhaler can be used as a reliever. Follow your doctor’s exact instructions.)

Why “Chronotherapy” Isn’t the Standard

You may wonder if you should simply take your medication right before bed to counter the natural 4:00 AM dip in lung function. While scientists are studying “smart” pills that release medicine at specific times, current clinical practice focuses on 24/7 stabilization [11][12].

The goal of modern therapy is to reach a level of control where your airways are so stable that the natural biological rhythms of the night no longer cause you to wake up [1]. If you are still waking up frequently, it usually means the “baseline” inflammation in your lungs is too high, rather than the timing of your dose being wrong [5].

Steps Before “Stepping Up”

If your nighttime symptoms persist, your doctor will likely review several factors before increasing your medication dose:

  • Inhaler Technique: If the medicine doesn’t reach the small airways deep in your lungs, it cannot prevent nighttime narrowing [5].
  • Adherence: Are you using your controller inhaler every single day, even when you feel well [13]?
  • Uncontrolled Triggers: Are issues like acid reflux (GERD) or sleep apnea (OSA) working against your asthma medication [5]?

By focusing on total airway stability rather than just “putting out fires” at 3:00 AM, most patients can work toward a future where they sleep through the night without interruption.

Common questions in this guide

What is the MART/SMART single-inhaler approach for nocturnal asthma?
When prescribed, MART or SMART uses one inhaler containing an inhaled corticosteroid and formoterol for both ongoing control and symptom relief. The corticosteroid treats airway inflammation, while formoterol helps open the airways. Not every combination inhaler can be used as a reliever, so follow your clinician’s instructions.
Is albuterol alone enough if asthma wakes me at night?
Albuterol is a short-acting reliever that can quickly relax airway muscles, but it does not treat the inflammation underlying asthma. Using it frequently, especially for nighttime symptoms, can signal that asthma is not well controlled and that a clinician should review controller treatment.
Should I take my asthma medicine only at bedtime?
Nighttime-only dosing is not the usual modern approach for asthma. Treatment generally aims to keep the airways stable around the clock, so repeated awakenings may mean that inflammation, inhaler technique, adherence, or another trigger needs review.
What should be checked before my asthma treatment is increased?
A clinician may check whether you use the inhaler correctly and take your controller medicine consistently. They may also look for problems that can worsen nighttime symptoms, including acid reflux and sleep apnea, before changing the dose.
How many puffs of my reliever inhaler can I take in 24 hours?
The safe maximum depends on the exact inhaler, your prescribed plan, and whether it is being used as a reliever in a MART/SMART regimen or a separate rescue inhaler. Ask your clinician to write the limit in your asthma action plan, and do not change the dose on your own.

Get notified when new evidence is published on nocturnal asthma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Asthma maintenance and reliever therapy: Should this be the standard of care?

    Cusack RP, Satia I, O'Byrne PM

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2020; (125(2)):150-155 doi:10.1016/j.anai.2020.04.009.

    PMID: 32339657
  2. 2

    Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

    Reddel HK, Bacharier LB, Bateman ED, et al.

    Respirology (Carlton, Vic.) 2022; (27(1)):14-35 doi:10.1111/resp.14174.

    PMID: 34668278
  3. 3

    Beta2-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care.

    Skolnik N, Stieritz J, Akers J, et al.

    Frontiers in medicine 2026; (13()):1826737 doi:10.3389/fmed.2026.1826737.

    PMID: 42305977
  4. 4

    Current perspectives on β2-adrenergic receptor agonists in asthma: navigating from track to track within GINA recommendations.

    Calzetta L, Rogliani P

    Expert opinion on pharmacotherapy 2026; (27(11)):1085-1095 doi:10.1080/14656566.2026.2702385.

    PMID: 42444391
  5. 5

    Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.

    Reddel HK, Bacharier LB, Bateman ED, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S1-S18 doi:10.1016/j.jaip.2021.10.001.

    PMID: 34718211
  6. 6

    A Practical Guide to Implementing SMART in Asthma Management.

    Reddel HK, Bateman ED, Schatz M, et al.

    The journal of allergy and clinical immunology. In practice 2022; (10(1S)):S31-S38 doi:10.1016/j.jaip.2021.10.011.

    PMID: 34666208
  7. 7

    Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.

    Aalbers R, Vogelmeier C, Kuna P

    Respiratory medicine 2016; (111()):1-7.

    PMID: 26614594
  8. 8

    AIR and MART approach to asthma treatment.

    Bhugra R

    Drug and therapeutics bulletin 2026; (64(7)):108-111 doi:10.1136/dtb.2023.000058.

    PMID: 42120188
  9. 9

    Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis.

    Rayner DG, Ferri DM, Guyatt GH, et al.

    JAMA 2025; (333(2)):143-152 doi:10.1001/jama.2024.22700.

    PMID: 39465893
  10. 10

    Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.

    Beasley R, Harrison T, Peterson S, et al.

    JAMA network open 2022; (5(3)):e220615 doi:10.1001/jamanetworkopen.2022.0615.

    PMID: 35230437
  11. 11

    Circadian-guided asthma therapy: compressed-coated chronotherapeutic tablets for precision early-morning drug delivery.

    Sindhu K, Kumar P, Kumar A, et al.

    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2026; (34(2)).

    PMID: 42435114
  12. 12

    Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma.

    Chauhan BF, Jeyaraman MM, Singh Mann A, et al.

    The Cochrane database of systematic reviews 2017; (3()):CD010347 doi:10.1002/14651858.CD010347.pub2.

    PMID: 28301050
  13. 13

    Repeated exacerbation of asthma: An intrinsic phenotype of uncontrolled asthma.

    Jain N, Satish K, Abhyankar N, et al.

    Lung India : official organ of Indian Chest Society 2019; (36(2)):131-138 doi:10.4103/lungindia.lungindia_434_17.

    PMID: 30829247

This page explains nighttime asthma treatment options for informational purposes only and does not constitute medical advice. Do not change inhaler doses or combine medicines without guidance from your prescribing clinician.